Molecular technologies play an important role in evolving medicine. Monitoring genes and their activities can accurately reveal individual health and disease conditions. We develop and market predictive and personalized medicine products. Our technology core focuses on protecting and identifying genes in peripheral blood samples.
The coronavirus disease outbreak began in December 2019. It is spreading rapidly throughout the world, becoming pandemic.
GS™ COVID-19 Real-Time PCR Kit was granted by the FDA Emergency Use Authorization for high throughput COVID-19 RT-PCR Diagnostic on April 16, 2020.
|2702-22||GS™ COVID-19 Real-Time PCR Kit - 22||Provide all-in-one master mix including cDNA synthesis, PCR mix, primers and probe of each gene.||22 samples||Request a quote|
|2702-94||GS™ COVID-19 Real-Time PCR Kit - 94||Provide all-in-one master mix including cDNA synthesis, PCR mix, primers and probe of each gene.||94 samples||Request a quote|
For use under the Emergency Use Authorization (EUA) only
For in vitro diagnostic use